An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy

Summary

The purpose of the trial is to assess the tolerability of the up-dosing phase of AVANZ Mite mix.

Timeline

Start

2011-12

Primary completion

2012-07

Completion

2012-07

Publications

• Tabar AI, Gonzalez Delgado P, Sanchez Hernandez C, Basagana Torrento M, Moreno Benitez F, Arina M. Phase II/III clinical trial to assess the tolerability and immunological effect of a new updosing phase of Dermatophagoides mix-based immunotherapy. J Investig Allergol Clin Immunol. 2015;25(1):40-6.

Drugs

Indications